FETUS
cesta životem
6th Central - Eastern European congress
on cell free DNA and medical practice
7-8 March 2024, Olomouc, hotel Clarion
Moving from NIPT to cancer screening - universality of low pass whole genome analysis Liquid biopsy, as the source of cell-free nucleic acid for the diagnosis, treatment, and monitoring of cancers Application of oncoMonitor liquid biopsy assay for monitoring of therapy and minimal residual disease in various solid cancers Detection of homologous recombination deficiency using cell-free DNA whole-genome sequencing profile in ovarian cancer Serous ovarian cancer microRNA profiling Preliminary European resultson the clinicalutility of ColonAiQ, a cell-free DNA methylation-based liquid biopsy assay for colorectal cancer early detection Cell-free DNA for prostate cancer progression monitoring Characterization of small non-coding RNAs in plasma of breast carcinoma patients by next-generation sequencing Mitochondrial DNA copy number as a minimally-invasive diagnostic biomarker of gliomas Detection of recurrent somatic variants in cell-free DNA as a tool for disease monitoring in Hodgkin lymphoma Circulating tumor DNA-based analyses of solid tumors Prenatal Screening in Czech Republic – history, present, future Recent discoveries in the characteristics and clinical significance of cell-free DNA in plasma An overview of prenatal cf-DNA screening methods: clinical efficacy and scope Potential of cfDNA aneuploidy screening to reduce invasive prenatal testing What we know about cell-free fetal DNA fragments Positioning, Performance and Relevance of Cell-based Noninvasive Prenatal Testing Avidity sequencing: Novel technology that expands possibilities of NGS applications cfDNA testing for trisomies in the UK Genome-wide non-invasive prenatal testing using cfDNA: the detection of rare autosomal trisomies Review: cfDNA and cfRNA screening for preeclampsia and preterm birth First trimester screening of pregnancyrelated complications Pitfalls in the development and implementation of non-invasive prenatal testing at the regional level - Trisomy test story NIPT and beyond Rapid non-invasive prenatal screening test for trisomy 21 based on digital droplet PCR Digital PCR in non-invasive prenatal testing Non – invasive prenatal screening and it´s relation to forensic practice NIPT in monogenic diseases: a current perspective NIPT in contingent screening protocol NIPT in the diagnosis of failed pregnancies dd-cf DNA as a tool to monitor antibody-mediated rejection in kidney transplantation Pathological role of neutrophilextracellulartraps-associated DNA in sterileinflammation The dynamics of extracellular DNA and neutrophil extracellular traps formation in mouse models of chronic liver disease The role of extracellular DNA in pathogenesis of rheumatoid arthritis 6-month-long fast-food intake is associated with worse metabolic syndrome score and higher ecDNA levels in female rats Extracellular DNA in saliva is protected from cleavage by DNase I Methodology challenges in isolation of circulating cell-free DNA from liquid biopsy samples in patients with colorectal adenoma
Zina Pecková
E fetmed@cbttravel.cz
T +420 606 918 277, +420 224 942 575, +420 224 942 579
FETMED s.r.o.
Horní Lán 1200/13, 779 00 Olomouc
Czech Republic
FETUS
cesta životem
Horní Lán 1312/12a, 7790 00 Olomouc, Czech Republic | T +420 605 825 780 | E asistent@fetmed.cz | www.fetmed.cz